Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow: A Randomized Double-Blind Placebo-Controlled Mechanistic Study.

Saved in:
Bibliographic Details
Title: Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow: A Randomized Double-Blind Placebo-Controlled Mechanistic Study.
Authors: Mahendiran T; Cardiovascular Center Aalst, AZORG, Aalst, Belgium; Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland., Wilgenhof A; Cardiovascular Center Aalst, AZORG, Aalst, Belgium; Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy., Corradetti S; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Viscusi M; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Heyse A; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., De Wolf T; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Aroudj N; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Browaeys S; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Claessens N; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Cobbaut I; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., De Block L; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., De Wolf K; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Delacroix H; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Girukwishaka E; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Mathieu E; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Van Cutsem K; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Van De Velde C; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Van Der Kelen P; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Verbeken L; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., De Gend I; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., De Vulder I; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Haeleydt N; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Heremans S; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Rooselaers K; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Verbeurgt A; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Verhelst D; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Van Laer E; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Nelis O; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Storozhenko T; Cardiovascular Center Aalst, AZORG, Aalst, Belgium; Department of Prevention and Treatment of Emergency Conditions, L.T. Malaya Therapy National Institute NAMSU, Kharkiv, Ukraine., Buytaert D; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Sonck J; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Johnson NP; Division of Cardiology, Department of Medicine, McGovern Medical School at University of Texas Health and Memorial Hermann Hospital, Houston, Texas, USA., Collet C; Cardiovascular Center Aalst, AZORG, Aalst, Belgium., Jüni P; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., De Bruyne B; Cardiovascular Center Aalst, AZORG, Aalst, Belgium; Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland. Electronic address: bernard.de.bruyne@gammas.be.
Source: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2026 Jul 13; Vol. 19 (13), pp. 1748-1762. Date of Electronic Publication: 2026 May 11.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101467004 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-7605 (Electronic) Linking ISSN: 19368798 NLM ISO Abbreviation: JACC Cardiovasc Interv Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first